Location History:
- Daegu, KR (2012 - 2016)
- Daejeon, KR (2019)
Company Filing History:
Years Active: 2012-2019
Title: Si Kyu Lim: Innovator in Genetic Testing and Neuroprotective Compositions
Introduction
Si Kyu Lim is a notable inventor based in Daegu, South Korea. He has made significant contributions to the fields of genetic testing and neuroprotective compositions. With a total of 3 patents to his name, Lim's work has the potential to impact both medical diagnostics and treatment options.
Latest Patents
One of Si Kyu Lim's latest patents is a method for testing a mutant gene through real-time polymerase chain reaction (PCR) using inhibition of 5'-flap endonuclease activity. This invention focuses on detecting single nucleotide polymorphism (SNP) by utilizing the unique feature that the 5'-flap endonuclease activity of DNA polymerase is inhibited when a probe binds to the end of a PCR product. This innovative approach allows for effective SNP detection by inducing 5'-flap formation according to the allele.
Another significant patent involves novel tacrolimus analogues, which are part of a neuroprotective composition. This invention includes a method for preparing these analogs using an isolated modified strain, which reduces the activity of specific enzymes. The compositions are aimed at preventing or treating neurological diseases and immune hypersensitivity disorders.
Career Highlights
Throughout his career, Si Kyu Lim has worked with prominent companies such as Genotech Corp. and Intron Biotechnology, Inc. His experience in these organizations has contributed to his expertise in the development of innovative medical solutions.
Collaborations
Si Kyu Lim has collaborated with notable coworkers, including Jae Jong Kim and Sun Ho Cha. These partnerships have likely enhanced his research and development efforts in the field.
Conclusion
Si Kyu Lim is a distinguished inventor whose work in genetic testing and neuroprotective compositions showcases his innovative spirit. His contributions have the potential to advance medical science and improve patient outcomes.